Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About John Evans

John Evans is recorded as CEO, Board Member and Chief Accounting Officer at Beam Therapeutics Inc. (BEAM) and Head of Investor Relations at GrowGeneration Corp. (GRWG). The proxy statement of Beam Therapeutics Inc. reports total compensation of $5,818,525 for John Evans in fiscal 2025, including a base salary of $755,000. Disclosed compensation is on record for 7 fiscal years. John Evans has spoken on 3 earnings calls and 1 other investor event across 2 companies, most recently for Beam Therapeutics Inc. on September 8, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Beam Therapeutics Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at GrowGeneration Corp.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Beam Therapeutics Inc. (BEAM) $755,000 $5,818,525
2024 Beam Therapeutics Inc. (BEAM) $715,750 $6,409,631
2023 Beam Therapeutics Inc. (BEAM) $685,000 $6,280,099
2022 Beam Therapeutics Inc. (BEAM) $650,000 $9,496,745
2021 Beam Therapeutics Inc. (BEAM) $590,105 $13,911,975
2020 Beam Therapeutics Inc. (BEAM) $529,271 $906,768
2019 Beam Therapeutics Inc. (BEAM) $472,500 $2,209,800

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.